Caterpillar stock rises as CAT tees up CES 2026 AI keynote, expands Nvidia tie-up

Caterpillar stock rises as CAT tees up CES 2026 AI keynote, expands Nvidia tie-up

New York, Jan 5, 2026, 12:46 EST — Regular session

  • Caterpillar shares climb as the company details an Industrial AI and autonomy showcase at CES 2026 Caterpillar Investors
  • CEO Joe Creed to headline a Jan. 7 CES keynote, with Nvidia’s Deepu Talla set to join Caterpillar executives onstage Caterpillar Investors
  • Investors also brace for Friday’s U.S. payrolls report and a late-January earnings window Bureau of Labor Statistics

Caterpillar (CAT.N) shares rose about 2.7% on Monday after the heavy-equipment maker said it will showcase new Industrial AI and autonomy initiatives at CES 2026 and deepen its collaboration with Nvidia (NVDA.O). Caterpillar Investors

The CES spotlight matters because Caterpillar has become a high-conviction industrial bellwether for investors who want exposure to automation, digital services and AI-enabled equipment — themes that can carry more weight when the macro picture turns choppy. Monday’s move came as traders weighed fresh U.S. factory data and the outlook for rates, both key swing factors for capital spending. Reuters

Caterpillar said Creed will deliver a keynote in Las Vegas on Wednesday, Jan. 7 at 9:00 a.m. PST, and Nvidia’s vice president of robotics and edge AI, Deepu Talla, will join Caterpillar leaders to announce an expanded collaboration. Caterpillar also plans live demonstrations, including AI-driven features on a Cat 306 mini excavator. Caterpillar Investors

Industrial AI, in plain terms, is using software to turn machine and jobsite data into real-time guidance and safety features. Autonomy means equipment can perform more tasks with less direct human control — a pitch aimed at productivity and labor constraints on worksites. Caterpillar Investors

At 12:46 p.m. EST, Caterpillar was up $16.31 at $614.72, after trading as high as $621.65 earlier in the session. The Industrial Select Sector SPDR ETF (XLI) was up about 1.5%, while the Dow ETF (DIA) gained about 1.6%. Deere (DE.N), a key peer, slipped about 0.6%.

“Technology is accelerating and expanding our ability to meet customer needs,” Creed said in the CES announcement. Caterpillar Investors

The company’s CES push landed on a day when a closely watched gauge of U.S. manufacturing weakened. The Institute for Supply Management’s manufacturing PMI fell to 47.9 in December; readings below 50 signal contraction. Reuters

Still, investors have been willing to look past softer factory indicators when they see durable demand tied to data infrastructure and electrification, themes that have helped reframe Caterpillar’s growth profile in recent market commentary. Investors

But the risk case has not gone away: Caterpillar remains exposed to swings in construction and mining activity, and a prolonged downturn in orders can hit dealer inventory moves and pricing power. Trade policy is another uncertainty, with tariffs lifting costs and complicating demand signals, according to recent U.S. manufacturing data and commentary. Reuters

Technically, Caterpillar is trading below its 52-week high of $627.50 but well above its 50-day moving average (about $573), leaving the $600 area in focus if momentum cools. The stock’s 52-week range is $267.30 to $627.50. Barchart

Next up, traders will watch Creed’s CES keynote on Jan. 7 and Friday’s U.S. jobs report, which the Labor Department has scheduled for 8:30 a.m. ET on Jan. 9. The most immediate company catalyst is the CES keynote itself. Caterpillar Investors

Stock Market Today

  • Lilly to buy Ventyx Biosciences for $1.2 billion as obesity-pill bets sharpen
    January 7, 2026, 5:16 PM EST. Eli Lilly shares rose after it agreed to buy Ventyx Biosciences for $1.2 billion, expanding beyond diabetes and weight-loss drugs. Lilly closed up 4.1% at $1,108.09, after touching $1,117.37, valuing the company near $1 trillion. The cash offer of $14 a share is a 62% premium to Ventyx's 30-day VWAP (volume-weighted average price); Lilly expects closing in H1 2026, pending votes and regulators; about 10% of Ventyx shares have signed support. Lilly's research chief Daniel Skovronsky cited inflammation as a disease driver; Ventyx CEO Raju Mohan called the tie a strategic fit. The broader market was mixed: S&P 500 down, Dow lower, Nasdaq up ahead of payrolls data. Nimbus Therapeutics struck an AI-enabled obesity collaboration with Lilly; Lilly also eyes Aktis Oncology's IPO.
Hut 8 Corp stock jumps 12% as bitcoin pushes higher — traders eye Friday jobs data
Previous Story

Hut 8 Corp stock jumps 12% as bitcoin pushes higher — traders eye Friday jobs data

CoreWeave stock erases early pop after rare Davidson upgrade — what CRWV investors watch next
Next Story

CoreWeave stock erases early pop after rare Davidson upgrade — what CRWV investors watch next

Go toTop